Baxter International | BAX - Debt


Baxter International reported $9.69B in Debt for its fiscal quarter ending in March of 2026.





Debt Change Date
Abbott USD 34.05B 20.19B Mar/2026
AngioDynamics USD 6.3M 6.3M Feb/2025
Artivion USD 317.78M 619K Dec/2024
AtriCure USD 71.78M 1.6M Mar/2026
Baxter International USD 9.69B 93M Mar/2026
Becton, Dickinson and Co. USD 17.28B 2.26B Mar/2026
Boston Scientific USD 11.03B 407M Mar/2026
Cooper Companies USD 2.46B 39.5M Mar/2026
Dexcom USD 1.24B 900K Mar/2026
Edwards Lifesciences USD 600M 105.4M Mar/2026
Fresenius EUR 11.9B 28M Mar/2026
Globus Medical USD 115.22M 3.43M Mar/2026
Halozyme Therapeutics USD 2.14B 2.01M Mar/2026
ICU Medical USD 1.23B 94.6M Jun/2026
Inogen USD 0 0 Jun/2022
Insulet USD 948.4M 300K Jun/2026
Integra LifeSciences USD 2.04B 6.27M Mar/2026
Intuitive Surgical USD 0 0 Mar/2025
J&J USD 54.99B 7.05B Mar/2026
Laboratory Of America USD 7.24B 714.6M Mar/2026
Medtronic USD 28.15B 192M Jun/2026
Merit Medical Systems USD 821.56M 9K Mar/2026
Quest Diagnostics USD 6.41B 179M Mar/2026
Stryker USD 14.19B 32M Jun/2026
Tandem Diabetes Care USD 602.58M 132.16M Jun/2026
Teleflex USD 2.69B 39.95M Mar/2026
Terumo JPY 379.8B 219.92B Mar/2026
Zimmer Biomet Holdings USD 7.48B 8M Jun/2026